Shares of Physiomics Plc (LON:PYC – Get Free Report) traded up 35.5% on Tuesday . The stock traded as high as GBX 1.10 ($0.01) and last traded at GBX 1.05 ($0.01). 20,006,418 shares traded hands during mid-day trading, an increase of 186% from the average session volume of 7,002,114 shares. The stock had previously closed at GBX 0.78 ($0.01).
Physiomics Stock Performance
The stock has a market cap of £2.13 million, a P/E ratio of -13.83 and a beta of 1.69. The business has a 50 day simple moving average of GBX 0.72 and a 200-day simple moving average of GBX 0.72.
Insider Activity at Physiomics
In other Physiomics news, insider Peter Sargent bought 459,090 shares of the business’s stock in a transaction on Thursday, November 7th. The stock was purchased at an average price of GBX 1 ($0.01) per share, for a total transaction of £4,590.90 ($5,617.84). 4.18% of the stock is owned by company insiders.
About Physiomics
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Featured Articles
- Five stocks we like better than Physiomics
- What Do S&P 500 Stocks Tell Investors About the Market?
- Is a Ford Stock Turnaround on the Horizon?
- What Are Earnings Reports?
- What PMI Data Says About the NFP Report: 3 Hidden Opportunities
- What is a SEC Filing?
- Cintas: Trade Uncertainty Creates a Buy-the-Dip Opportunity
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
